ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
COVID-19 could cause long-term lung damage, research finds pharmatimes
December 01, 2020Research conducted at Oxford University suggests that COVID-19 may be causing lung-damage in patients that can be detected over three months after the initial infection. -
Xenon Pharmaceuticals' acne drug XEN801 fails in mid-stage trial
firstwordpharma
March 27, 2017Xenon Pharmaceuticals announced Friday that a Phase II study of the experimental drug XEN801 for the treatment of moderate to severe facial acne failed to meet its primary endpoint. Shares in the company fell as much as 45 percent on the news.
Pharma Sources Insight July 2025
